Ulmi Cortex Extract Inhibits Apoptosis via PI3K/Akt Pathway
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutic methods are inadequate for effectively preventing and treating ovarian aging and premature ovarian failure, which can lead to reduced fertility and early menopause, due to the toxic effects of harmful factors on ovarian tissues and germ cells.
Innovation Solution
Administration of an Ulmi cortex extract, obtained from the bark of Ulmus macrocarpa Hance, which is processed into a pharmaceutical or food composition, to inhibit ovotoxicity and protect ovarian cells from damage, thereby preventing or treating ovarian aging and premature ovarian failure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional therapeutic methods are used for preventing and treating ovarian aging, then general body aging can be addressed, but ovarian-specific aging and premature ovarian failure cannot be adequately treated
Solution Approach 1:
The patent segments the therapeutic approach by specifically targeting ovarian tissue with Ulmi cortex extract, separating ovarian aging treatment from general body aging treatment. This allows the composition to address ovarian-specific cellular mechanisms while maintaining overall health benefits.
Solution Approach 2:
Ulmi cortex extract acts as an intermediary substance that mediates protection between ovarian cells and ovotoxic factors. The extract contains specific compounds that intervene in the toxic pathway, preventing direct damage to ovarian tissues while being administered systemically.
2Reliability
If ovarian aging is treated only by addressing general body aging, then overall health can be maintained, but fertility preservation and prevention of premature ovarian failure are insufficient
Solution Approach 1:
The Ulmi cortex extract composition performs multiple functions simultaneously: it protects against general aging, prevents ovotoxicity, preserves fertility, and treats premature ovarian failure. This multi-functional approach simplifies the treatment regimen while addressing multiple ovarian health concerns.
Solution Approach 2:
The patent emphasizes preliminary protection against ovotoxicity before irreversible ovarian damage occurs. By administering the extract proactively to prevent cellular damage, the treatment preserves fertility and prevents premature ovarian failure before clinical symptoms manifest.
3Reliability
If high concentrations of Ulmi cortex extract are used to maximize protective effects, then ovotoxicity inhibition is improved, but potential side effects and toxicity may increase
Solution Approach 1:
The patent optimizes the concentration parameters of Ulmi cortex extract in the composition to achieve maximum protective effect while minimizing potential toxicity. By carefully controlling the extract concentration and formulation parameters, the composition achieves therapeutic efficacy with an improved safety profile.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Ulmi cortex extract demonstrates protective effects against ovotoxicity by inhibiting apoptosis and activating the PI3K/Akt signaling pathway, effectively preventing or alleviating ovarian aging and premature ovarian failure, as shown by its antioxidant activity and cell viability preservation in preclinical studies.
Implementation Method 1
The Ulmi cortex extract demonstrates protective effects against ovotoxicity by inhibiting apoptosis and activating the PI3K/Akt signaling pathway
Implementation Method 2
as shown by its antioxidant activity and cell viability preservation in preclinical studies
Data Source
AI summary
Provided is a method of treating ovotoxicity of an individual, including administering an Ulmi cortex extract to an individual in need of treatment. The present disclosure may exhibit an effect of preventing, alleviating, or treating ovarian aging or premature ovarian failure by inhibiting oxidative stress or ovotoxicity of the ovaries.


